20th Clinical Trials Innovation Programme: October 26 – 27, 2022

Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development industry.

Hear from CEO Dr Adam Vogel and other leading industry experts exploring the future of clinical trials, patient centricity, and drug development digitalisation post COVID. 26 – 27 October 2022, Boston.

To find out more and register, click here.

Related Post

  • Posted on 31 October, 2024
    Remote speech tests can complement in-clinic exams to help guide treatment for Multiple Sclerosis (MS). Previous studies suggested that speech...
    • Posted on 14 October, 2024
      Redenlab is pleased to announce that Dr. Adam Vogel, an expert in speech and language function, will be presenting at...
      • Posted on 4 September, 2024
        Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy at Takeda,...